Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan Province.
Department of Neurology, Renmin Hospital, Yunyang Medical College, Shiyan, Hubei Province, China.
Eur J Neurol. 2011 Feb;18(2):362-364. doi: 10.1111/j.1468-1331.2010.03082.x.
Dopa-responsive dystonia has been shown to be caused by a number of different mutations in the GCH1 gene. Up to now, only several genetic studies of Chinese patients with Dopa-responsive dystonia (DRD) have been reported.
We performed a genetic analysis by amplifying the entire coding region of GCH1 gene and direct sequencing in four DRD families from mainland China.
A novel missense mutation, Gly155Ser, has been identified in a sporadic case from a consanguineous marriage family. Furthermore, two known mutations, Met137Arg and Gly203Arg, have also been detected in the other families.
A novel missense mutation in the GCH1 gene can be associated with DRD. Our findings further expanded the mutational spectrum of GCH1 gene associated with DRD.
多巴反应性肌张力障碍是由 GCH1 基因的许多不同突变引起的。到目前为止,只有少数几项针对中国多巴反应性肌张力障碍(DRD)患者的遗传研究报告。
我们对来自中国大陆的四个 DRD 家系进行了 GCH1 基因全长编码区扩增和直接测序的遗传分析。
在一个来自近亲结婚家庭的散发病例中发现了一个新的错义突变 Gly155Ser。此外,在其他两个家系中还检测到了两个已知的突变 Met137Arg 和 Gly203Arg。
GCH1 基因中的一个新的错义突变与 DRD 有关。我们的发现进一步扩展了与 DRD 相关的 GCH1 基因突变谱。